Cargando…

Prognostic nomogram for previously untreated adult patients with acute myeloid leukemia

This study was designed to perform an acceptable prognostic nomogram for acute myeloid leukemia. The clinical data from 311 patients from our institution and 165 patients generated with Cancer Genome Atlas Research Network were reviewed. A prognostic nomogram was designed according to the Cox's...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Zhuojun, Li, Xiaodong, Zhu, Yuandong, Gu, Weiying, Xie, Xiaobao, Jiang, Jingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342098/ https://www.ncbi.nlm.nih.gov/pubmed/27689396 http://dx.doi.org/10.18632/oncotarget.12245

Ejemplares similares

miR-183-5p Inhibits Occurrence and Progression of Acute Myeloid Leukemia via Targeting Erbin
por: Zheng, Zhuojun, et al.
Publicado: (2019)

Impact of marital status during diagnosis on cancer-caused specific survival in acute myeloid leukemia patients: a case-control and population-based study
por: Zheng, Zhuojun, et al.
Publicado: (2017)

Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine
por: Zhang, Alexander, et al.
Publicado: (2022)

Prognostic nomogram for adult patients with acute myeloid leukemia: A SEER database analysis
por: Chen, Cunte, et al.
Publicado: (2019)

Identification of Circulating MicroRNAs as Potential Biomarkers for Detecting Acute Myeloid Leukemia
por: Zhi, Feng, et al.
Publicado: (2013)

Prognostic Nomogram for Acute Myeloid Leukemia Patients With Biallelic CEBPA Mutations
por: Xu, Xiaoyu, et al.
Publicado: (2021)

Development of a Prognostic Nomogram for Acute Myeloid Leukemia on IGHD Gene Family
por: Qiu, Qunxiang, et al.
Publicado: (2021)

Nomogram incorporating clinicopathological parameters to predict the survival of patients with mantle cell lymphoma
por: Zhu, Yuandong, et al.
Publicado: (2019)

A Case of Acute Myeloid Leukemia Concurrent With Untreated Chronic Lymphocytic Leukemia
por: Lee, Hye-Young, et al.
Publicado: (2017)

MicroRNA expression profile in Treg cells in the course of primary immune thrombocytopenia
por: Zhu, Yuandong, et al.
Publicado: (2019)

Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive Therapy
por: Sarlo, Chiara, et al.
Publicado: (2013)

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study
por: Wei, Andrew H., et al.
Publicado: (2019)

Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia
por: Hill, Brian T, et al.
Publicado: (2015)

Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
por: Xia, Leiming, et al.
Publicado: (2023)

Prognostication refinement in NPM1‐mutated acute myeloid leukemia stratified by FLT3‐ITD status with different induction doses of cytarabine
por: Wang, Biao, et al.
Publicado: (2023)

Decitabine combined with all-trans retinoic acid as treatment in a case of primary myelofibrosis transforming into acute myeloid leukaemia
por: Lin, Yan, et al.
Publicado: (2019)

The Prognostic Value of Sarcopenia in Acute Myeloid Leukemia Patients and the Development and Validation of a Novel Nomogram for Predicting Survival
por: Sun, Qian, et al.
Publicado: (2022)

A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy
por: Duan, Jingjing, et al.
Publicado: (2018)

Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
por: Yamamoto, Kazuhito, et al.
Publicado: (2021)

A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia
por: Schimmer, Aaron D., et al.
Publicado: (2014)

A Simple-to-Use Nomogram for Predicting Survival in Children with Acute Myeloid Leukemia
por: Jiang, Feng, et al.
Publicado: (2021)

Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics
por: Gregory, Tara K, et al.
Publicado: (2009)

The prognostic relevance and expression of progranulin in adult patients with acute myeloid leukemia
por: Qin, Jiajia, et al.
Publicado: (2020)

Low-dose decitabine for previously untreated acute myeloid leukemia ineligible for intensive chemotherapy aged 65 years or older: a prospective study based on comprehensive geriatric assessment
por: Feng, Ru, et al.
Publicado: (2023)

Correction to: Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
Publicado: (2023)

Predictors of the Overall Survival with Azacitidine Monotherapy in Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Therapy
por: Taenaka, Ryutaro, et al.
Publicado: (2022)

DesA Prognostic Risk Model of LncRNAs in Patients With Acute Myeloid Leukaemia Based on TCGA Data
por: Ding, Weidong, et al.
Publicado: (2022)

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)
por: Vernerey, Dewi, et al.
Publicado: (2016)

The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid Leukemia
por: Pogosova-Agadjanyan, Era L., et al.
Publicado: (2013)

SPRED1 Is Downregulated and a Prognostic Biomarker in Adult Acute Myeloid Leukemia
por: Zhang, Rui, et al.
Publicado: (2020)

Serum miR‐22 is a novel prognostic marker for acute myeloid leukemia
por: Qu, Hong, et al.
Publicado: (2020)

Acute myeloid leukemia in the older adults
por: Almeida, Antonio M., et al.
Publicado: (2016)

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)
por: Al-Kali, Aref, et al.
Publicado: (2010)

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia
por: Griggio, Valentina, et al.
Publicado: (2016)

A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia
por: Izutsu, Koji, et al.
Publicado: (2020)

Suppressive effects of simvastatin on the human acute promyelocytic leukemia NB4 cell line through the regulation of the nuclear factor-κB signaling pathway
por: QIU, GUOQIANG, et al.
Publicado: (2014)

Identification of prognostic genes in the acute myeloid leukemia microenvironment
por: Huang, Shaoxin, et al.
Publicado: (2019)

miRNAs as prognostic predictors in acute myeloid leukemia
por: Machado-Neto, João Agostinho, et al.
Publicado: (2023)

SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia
por: Yue, Can, et al.
Publicado: (2021)

P516: CARDIOTOXICITY OF CPX-351 VS 7 + 3 IN PATIENTS WITH UNTREATED HIGH-RISK ACUTE MYELOID LEUKEMIA
por: Mitchell, Joshua D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o0pcasiem4uqebkic9d8hqa458